Blog

 

Blog

Queen's speech paves the way for Brexit

21 June 2017

By Charles Brasted and Peter Watts

The Queen's Speech has set out the UK Government's intended legislative programme for the next two years – and its focus is Brexit. 

While there is little to no new detail, there are some further hints of how the Government intends to approach the task of implementing Brexit in the UK while negotiations with the EU continue.  

Read more

Jurisdictions: United Kingdom

Blog

Force Maijoor: supervisory convergence - a view of the impact from Italy

6 June 2017

By Jeffrey Greenbaum

On 11 April 2017, Steven Maijoor, the Chair of the European Securities and Markets Authority ("ESMA") addressed the potential regulatory issues which may affect EU Member States as a result of the Brexit effect on passporting rights ceasing to work across UK and EU borders. He noted that ESMA would work to eliminate "competition on regulatory and supervisory practices between member states, and a possible race to the bottom". On 31 May ESMA announced its general principles to support supervisory convergence in the context of the United Kingdom withdrawing from the European Union (the "General Principles"). Among other things, the principles call for rigorous and efficient authorisations and state there cannot be any automatic recognition of the authorisation granted by the UK regulator into the EU27.

Read more

Industries: Financial Institutions
Jurisdictions: Italy
Services: Financial Services

Blog

Relocation of the EU Medicines Agency – Spain

2 June 2017

By Álvaro Abad

"Spain is waiting for the EMA.  Barcelona is ready".  With this conviction, and with the conviction that everything is ready, the Spanish Minister for Health addressed the European Commissioner for Health & Food Safety, Mr Vytenis Andriukaitis, to express the desire of the Spanish Government – and, in particular, the Catalonia Government and the city of Barcelona – to become the next headquarters of the EMA.

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: Spain

Blog

Relocation of the EU Medicines Agency – Germany

8 May 2017

By Dr. Tanja Eisenblaetter

"EMA" and "gErMAny" – far more in common than mere letters

The European Medicines Agency (the "EMA"/"Agency") has reached celebrity-style status in the aftermath of the Brexit vote, and is being wooed by most European countries.  Whilst there are plausible arguments for a relocation of the EMA to any one of those wonderful European countries with delicious food, I wish – all prejudices against German food aside and I won’t mention Bratwurst – to point out some germane facts. gErMAny's bond with the EMA is already close – and not merely because it is in our name.  Each of the letters we share actually stands for a compelling reason for the Agency to relocate to Germany:

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: Germany

Blog

Stuck in the middle without EU: UK courts grapple with Brexit uncertainty

5 May 2017

By Charles Brasted and Andrew Eaton

One of the UK Government's central objectives for Brexit is to bring an end to the jurisdiction in the UK of the Court of Justice of the EU ("CJEU").  A necessary implication of this objective is that, unless agreed otherwise during the Article 50 negotiations, citizens and businesses seeking a determination of their legal claims in the UK courts will lose their ability to make references to the CJEU on questions of EU law after Brexit takes effect. 

Now that Article 50 has been triggered, the UK courts are starting to be asked to address the legal uncertainty this raises for those with legal proceedings outstanding during the Brexit negotiation period: where questions of EU law arise after Brexit in cases filed in the UK courts before Brexit, how and by whom will these questions be determined?

Read more

Jurisdictions: United Kingdom
Services: Administrative and Public Law, Pensions, Tax